Jul/Aug 2007 - Hormone Replacement Therapy

Purchase or view individual articles by selecting the article in the table below...

Individual Articles - Jul/Aug 2007 - Hormone Replacement Therapy

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2007 Pg. 266	PreScription: Bias, NAMS, and HRT Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 269-272	Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature Author(s): Paoletti Jim, Kaul Monica, Kloesel Lawson G
Jul/Aug 2007 Pg. 274-277	The History of Progesterone Author(s): Newton Stephen J
Jul/Aug 2007 Pg. 278-281	The Politics of Hormone Replacement Therapy Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 282-286	Premarin: The Intriguing History of a Controversial Drug Author(s): Vance Dwight A
Jul/Aug 2007 Pg. 288-291	Common Acronyms Used by Health Professionals Who Prescribe or Prepare Hormone Replacement Author(s): Price Dared L
Jul/Aug 2007 Pg. 292-296	The Lived Experience of Perimenopausal and Menopausal Women Undergoing Treatment with Bioidentical Hormones Author(s): Holt-Waldo NaRisa Y, Stephenson Kenna
Jul/Aug 2007 Pg. 297-298	Obtaining Accreditation by the Pharmacy Compounding Accreditation Board, Part 1: An Overview Author(s): Cabaleiro Joe
Jul/Aug 2007 Pg. 300	Book Review: The Rexall Story: A History of Genius and Neglect Author(s): Grajeda Betty Jo
Jul/Aug 2007 Pg. 302-305	Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Author(s): Okeke Claudia C
Jul/Aug 2007 Pg. 306-311	Quality-control Analytical Methods: Logbooks and Documentation Forms Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 314-323	Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2 Author(s): Allen Loyd V Jr, Okeke Claudia C
Jul/Aug 2007 Pg. 324	Calculations Author(s): Stockton Shelly J
Jul/Aug 2007 Pg. 326-327	Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration Author(s): Kupiec Tom, Kemp Jesse
Jul/Aug 2007 Pg. 328	Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 329	Ketoconazole 25-mg Liquid Suppository Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 330	Mebeverine Hydrochloride 20% gel Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 331	Moxifloxacin in Dianeal 1.36% Peritoneal Dialysis Solution Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 332	Oseltamivir 12-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 333	Phenytoin Sodium 20-mg/mL Topical Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 334	Ribavirin 40-mg/mL Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 335	Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 336	Temozolomide 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 337	Vehicle N Formulas Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 338-346	Statistical Analysis of Barrier Isolator/Glovebox Glove Failure Author(s): Park Young H, Pines E, Ofouku M, Cournoyer ME
Jul/Aug 2007 Pg. 347-348	Chemical Stability of Cyproheptadine Hydrochloride in an Oral Liquid Dosage Form Author(s): Gupta Vishnu D
Jul/Aug 2007 Pg. 350-351	PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 Author(s): Allen Loyd V Jr